Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > What?

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Apr 27, 2023 9:49am

112 Views

Post# 35416740

RE:RE:RE:RE:RE:What?

I'm sure someone at TLT is looking at these sort of poor 90 day CR results at the latest 90 day cohort, and also the 360 day. To see if there is something not happening correctly at the clinics?

It seems odd that they would have such a solid 90 day result for the Cohort at 450 days and not be able to repeat that in all cohorts.

<< Previous

Bullboard Posts

Next >>

The top 10 artificial intelligence penny stocks